BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Sosei Co., Ltd. 

4F, Kojimachi NK Building
2-14-2 Kojimachi, Chiyoda-ku
Tokyo    102-0083  Japan
Phone: 81-3-5210-3290 Fax: 81-3-5210-3291


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
BioAlliance Pharma Pursues the Development Plan of Its Loramyc® in Japan Through Its Partner Sosei 3/12/2013 12:05:50 PM
BioAlliance Pharma: Progress in the Development of Loramyc(R) in Japan Towards its Registration by the Partner Sosei Co., Ltd. 7/2/2012 12:31:19 PM
BioAlliance Pharma Expands its Loramyc(R) Franchise in Japan With Sosei Co., Ltd. in a Deal Valued up to 18.5M$ 5/11/2011 9:58:06 AM
BioAlliance Expands its Loramyc(R) Franchise in Japan with Sosei Co., Ltd. in a Deal Valued up to $18.5 Million 5/11/2011 6:43:57 AM
Novartis AG, Sosei Co., Ltd. COPD Drug Phase III Trial Meets Primary Endpoint 4/19/2011 7:11:21 AM
Sosei Co., Ltd. Agrees Terms With ASKA Pharmaceutical for Commercialization of SOH-075 (NorLevo(R)) 10/22/2008 9:38:52 AM
Sosei Co., Ltd. Announces Outcome of Strategy Review 5/14/2008 11:35:19 AM
Sosei Co., Ltd. Announces Start of AD 923 Phase III Studies in Europe 2/12/2008 7:22:00 AM
Sosei Co., Ltd. and Vectura Group plc Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 11/15/2007 7:19:46 AM
Sosei Co., Ltd. Announces Start of SD118 Phase I Studies 5/29/2007 10:49:30 AM
12345